#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 19

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Glycogen storage disease type II

Not recruiting

InvestigationalNo placebo

Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

InvestigationalNo placebo

Germany

Participants:0–17 years
Substances:Cipaglucosidase Alfa

Contact Research Centre

Macular oedema+1

Not recruiting

Registered drugNo placebo

Study on Ranibizumab Injections and Laser Treatment for Macular Edema in Central Retinal Vein Occlusion Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ranibizumab

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bictegravir

Contact Research Centre

B-cell type acute leukaemia

Not recruiting

InvestigationalNo placebo

Study on the Safety of Epcoritamab for Children and Young Adults with Relapsed or Refractory Aggressive B-cell Lymphomas

InvestigationalNo placebo

Germany

Participants:0–17 years
Substances:Epcoritamab

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Bleomycin

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Seralutinib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Not recruiting

Registered drugNo placebo

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Dacarbazine

Contact Research Centre

Hepatitis D

Not recruiting

Registered drugNo placebo

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bulevirtide

Contact Research Centre

Pulmonary hypertension

Not recruiting

Investigational

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.